Skip to content

MV-MLCF: A Semi-Supervised Self-training Method for Peptide Function Prediction Based on Multi-View and Multi-Label Co-Forest.

Sep 2026 · IEEE transactions on computational biology and bioinformatics · Vol PP · 0 citations
Medicine

TL;DR

The results show that the proposed MV MLCF method significantly improves prediction accuracy and outperforms comparison algorithms, highlighting its potential in accelerating peptide-based drug discovery and reducing experimental costs.

Abstract

Peptides, as biologically active molecules, have gained significant attention due to their therapeutic potential in treating various diseases, including metabolic disorders, cancers, and infectious diseases. However, the identification and functional annotation of multifunctional therapeutic peptides (MTPs) still remain challenging due to the limitations of traditional experimental costs and the scarcity of high-quality labeled data. To address these issues, we propose a novel semi-supervised self-training method called MV-MLCF (Multi-View and Multi-Label Co-Forest). MV-MLCF leverages multi-view feature representation techniques to comprehensively represent peptide sequences and employs a co-forest framework to iteratively label unannotated instances with a small set of high-quality labeled samples. By integrating multi-label learning, MV-MLCF effectively captures the multifunctional nature of peptides and lowers dependency on extensive labeled datasets. Extensive experiments across three benchmark datasets demonstrate the robustness and generalization of MV-MLCF across multiple base classifiers, including logistic regression, naive Bayes, and extreme learning machines. The results show that the proposed MV MLCF method significantly improves prediction accuracy and outperforms comparison algorithms, highlighting its potential in accelerating peptide-based drug discovery and reducing experimental costs. This study provides a new perspective and methodology for peptide function prediction, and offers a scalable and efficient solution to overcome data scarcity and enhance prediction performance in computational biology and bioinformatics.

View source

Similar papers

Oct 2026

DPLG-MFP: Enhanced prediction of multi-functional therapeutic peptides via dual-path learning of label sequences and label graphs.

Multi-functional therapeutic peptides play essential roles in diverse biological processes and hold great promise in drug discovery and biotechnology. Accurate prediction of peptide functions is crucial for understanding their biological activities and facilitating the design of peptide-based therapeutics. To this end,...

Yao Li, Guo-Liang Jing, Teng Zhang et al. · 0 citations
Open access Oct 2026

Identifying Anticancer Peptide via a Semi-Supervised Prediction Framework with Bio-Inspired Augmentation

A semi-supervised prediction framework with bio-inspired data augmentation for ACP identification, called AugACP, which incorporates semantic knowledge into masked Transformer pretraining to guide ACP sequence augmentation and provide more reliable supervised signals.

Xuan Liu, Yu-Qing Yang, Tong Zhao · 0 citations
Open access Sep 2026

HD-AIP: a heterogeneous dual-stream alignment-free framework for anti-inflammatory peptide prediction based on language models and CT-Net

Abstract Motivation Anti-inflammatory peptides (AIPs) show therapeutic potential for treating chronic and autoimmune diseases. Computational screening of these peptides remains challenging because their typically short sequences limit traditional feature extraction effectiveness, while homology-based methods incur high...

Jiang-Li Li, Quan Zou, Yan-Su Wang et al. · 0 citations
Open access Sep 2026

MetExPred: A Comprehensive Prediction Framework with Protein-Context-Aware Multi-view Learning for Drug Metabolism and Excretion

Within the ADMET continuum, metabolism and excretion (ME) form a critical bridge between drug exposure established by absorption and distribution and downstream efficacy and toxicity. However, no existing framework for drug ME prediction has simultaneously achieved broad coverage of endpoints and robust data recency an...

Yu-Xin Huang, Jing-Ting Wan, Gexuyang Wu et al. · 0 citations
Sep 2026

Cancer-ACPNet: A Two-Stage ESM-2 and Capsule Network Framework for Anticancer Peptide Screening and Cancer-Type Activity Prediction.

Anticancer peptides (ACPs) are being widely studied as potential peptide-based anticancer agents because of their ability to interact selectively with cancer cells. Despite this promise, computational identification of ACPs and prediction of their cancer-type activity remain difficult, mainly because available peptide...

Adeela Ashraf, Dong-Jun Yu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.